Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Find enclosed the intimation regarding loss of share certificate(s) of the shareholder(s) of the Company.08-11-2023
08-11-2023
Procter & Gamble Health Ltd - 500126 - Business Responsibility and Sustainability Reporting (BRSR)
Find enclosed the Business Responsibility and Sustainability Report of the Company for the Financial Year ended June 30,202308-11-2023
Procter & Gamble Health Ltd - 500126 - Reg. 34 (1) Annual Report.
Find enclosed the Annual Report for the Financial Year ended June 30,2023.08-11-2023
Procter & Gamble Health Ltd - 500126 - Annual Report And Notice Calling The 56Th Annual General Meeting Of The Company For The Financial Year Ended June 30, 2023.
Find enclosed Annual Report and Notice calling the 56th Annual General Meeting of the Company for the Financial Year ended June 30,202308-11-2023
Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are enclosing the press release on the unaudited financial results for the quarter ended September 30,2023.03-11-2023
Procter & Gamble Health Ltd - 500126 - Unaudited Financial Results For The Quarter Ended September 30, 2023 And Intimation Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015
Find enclosed unaudited financial results for the quarter ended September 30,2023.03-11-2023
Procter & Gamble Health Ltd - 500126 - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended September 30, 2023 And Intimation Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosures Requirements) Regulations, 2015
We are pleased to inform you that at a meeting of the Board of Directors of the Company held today (commenced at 7:05 pm and ended at 7:44 pm), the Unaudited Financial Results for the quarter ended September 30, 2023 were approved. We are enclosing herewith the following: a. Unaudited Financial Results for the quarter ended September 30, 2023; and b. Limited Review Report in respect of the Unaudited Financial Results for the quarter ended September 30, 2023 furnished by Statutory Auditors of the Company. Kindly take the same on record. Thanking you.03-11-2023
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, We are updated by our RTA regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.02-11-2023
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear All, We have been informed by our RTA regarding loss of share certificate of our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.02-11-2023
Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, We have issued duplicate share certificate to our shareholder, as detailed in attached letter. Request you to kindly take note of the same. Thanking you.31-10-2023